Key facts
- Protagonist Therapeutics director Waddill sold 80,000 shares of common stock.
- The value of the transaction was $896,760.
- The sale was reported on Tuesday.
Insider trading reports, such as Form 4 filings with the SEC, provide transparency into stock transactions made by company insiders like directors and officers. These filings can offer insights into an insider's confidence in the company's future prospects.